Identification and verification of plasma protein biomarkers that accurately identify an ectopic pregnancy.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Lynn A Beer, Xiangfan Yin, Jianyi Ding, Suneeta Senapati, Mary D Sammel, Kurt T Barnhart, Qin Liu, David W Speicher, Aaron R Goldman
{"title":"Identification and verification of plasma protein biomarkers that accurately identify an ectopic pregnancy.","authors":"Lynn A Beer, Xiangfan Yin, Jianyi Ding, Suneeta Senapati, Mary D Sammel, Kurt T Barnhart, Qin Liu, David W Speicher, Aaron R Goldman","doi":"10.1186/s12014-023-09425-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Differentiating between a normal intrauterine pregnancy (IUP) and abnormal conditions including early pregnancy loss (EPL) or ectopic pregnancy (EP) is a major clinical challenge in early pregnancy. Currently, serial β-human chorionic gonadotropin (β-hCG) and progesterone are the most commonly used plasma biomarkers for evaluating pregnancy prognosis when ultrasound is inconclusive. However, neither biomarker can predict an EP with sufficient and reproducible accuracy. Hence, identification of new plasma biomarkers that can accurately diagnose EP would have great clinical value.</p><p><strong>Methods: </strong>Plasma was collected from a discovery cohort of 48 consenting women having an IUP, EPL, or EP. Samples were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) followed by a label-free proteomics analysis to identify significant changes between pregnancy outcomes. A panel of 14 candidate biomarkers were then verified in an independent cohort of 74 women using absolute quantitation by targeted parallel reaction monitoring mass spectrometry (PRM-MS) which provided the capacity to distinguish between closely related protein isoforms. Logistic regression and Lasso feature selection were used to evaluate the performance of individual biomarkers and panels of multiple biomarkers to predict EP.</p><p><strong>Results: </strong>A total of 1391 proteins were identified in an unbiased plasma proteome discovery. A number of significant changes (FDR ≤ 5%) were identified when comparing EP vs. non-EP (IUP + EPL). Next, 14 candidate biomarkers (ADAM12, CGA, CGB, ISM2, NOTUM, PAEP, PAPPA, PSG1, PSG2, PSG3, PSG9, PSG11, PSG6/9, and PSG8/1) were verified as being significantly different between EP and non-EP in an independent cohort (FDR ≤ 5%). Using logistic regression models, a risk score for EP was calculated for each subject, and four multiple biomarker logistic models were identified that performed similarly and had higher AUCs than models with single predictors.</p><p><strong>Conclusions: </strong>Overall, four multivariable logistic models were identified that had significantly better prediction of having EP than those logistic models with single biomarkers. Model 4 (NOTUM, PAEP, PAPPA, ADAM12) had the highest AUC (0.987) and accuracy (96%). However, because the models are statistically similar, all markers in the four models and other highly correlated markers should be considered in further validation studies.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503165/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12014-023-09425-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Differentiating between a normal intrauterine pregnancy (IUP) and abnormal conditions including early pregnancy loss (EPL) or ectopic pregnancy (EP) is a major clinical challenge in early pregnancy. Currently, serial β-human chorionic gonadotropin (β-hCG) and progesterone are the most commonly used plasma biomarkers for evaluating pregnancy prognosis when ultrasound is inconclusive. However, neither biomarker can predict an EP with sufficient and reproducible accuracy. Hence, identification of new plasma biomarkers that can accurately diagnose EP would have great clinical value.

Methods: Plasma was collected from a discovery cohort of 48 consenting women having an IUP, EPL, or EP. Samples were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) followed by a label-free proteomics analysis to identify significant changes between pregnancy outcomes. A panel of 14 candidate biomarkers were then verified in an independent cohort of 74 women using absolute quantitation by targeted parallel reaction monitoring mass spectrometry (PRM-MS) which provided the capacity to distinguish between closely related protein isoforms. Logistic regression and Lasso feature selection were used to evaluate the performance of individual biomarkers and panels of multiple biomarkers to predict EP.

Results: A total of 1391 proteins were identified in an unbiased plasma proteome discovery. A number of significant changes (FDR ≤ 5%) were identified when comparing EP vs. non-EP (IUP + EPL). Next, 14 candidate biomarkers (ADAM12, CGA, CGB, ISM2, NOTUM, PAEP, PAPPA, PSG1, PSG2, PSG3, PSG9, PSG11, PSG6/9, and PSG8/1) were verified as being significantly different between EP and non-EP in an independent cohort (FDR ≤ 5%). Using logistic regression models, a risk score for EP was calculated for each subject, and four multiple biomarker logistic models were identified that performed similarly and had higher AUCs than models with single predictors.

Conclusions: Overall, four multivariable logistic models were identified that had significantly better prediction of having EP than those logistic models with single biomarkers. Model 4 (NOTUM, PAEP, PAPPA, ADAM12) had the highest AUC (0.987) and accuracy (96%). However, because the models are statistically similar, all markers in the four models and other highly correlated markers should be considered in further validation studies.

Abstract Image

Abstract Image

Abstract Image

血浆蛋白生物标志物的鉴定和验证可准确识别异位妊娠。
背景:区分正常的宫内妊娠(IUP)和异常情况,包括早孕丢失(EPL)或异位妊娠(EP)是早孕的主要临床挑战。目前,β-人绒毛膜促性腺激素(β-hCG)和孕激素系列是在超声不确定的情况下评估妊娠预后最常用的血浆生物标志物。然而,这两种生物标志物都不能以足够和可重复的准确性预测EP。因此,寻找能够准确诊断EP的血浆生物标志物具有重要的临床价值。方法:从48名经IUP、EPL或EP同意的女性中收集血浆。采用液相色谱-串联质谱(LC-MS/MS)对样品进行分析,然后进行无标记蛋白质组学分析,以确定妊娠结局之间的显著变化。然后在74名女性的独立队列中使用靶向平行反应监测质谱(PRM-MS)的绝对定量验证了14个候选生物标志物,该方法提供了区分密切相关蛋白质亚型的能力。使用逻辑回归和Lasso特征选择来评估单个生物标志物的性能,并使用多种生物标志物的组合来预测EP。结果:在一个无偏的血浆蛋白质组学发现中,共鉴定了1391个蛋白质。当比较EP与非EP (IUP + EPL)时,发现了许多显著变化(FDR≤5%)。接下来,在独立队列中验证14个候选生物标志物(ADAM12、CGA、CGB、ISM2、NOTUM、PAEP、PAPPA、PSG1、PSG2、PSG3、PSG9、PSG11、PSG6/9和PSG8/1)在EP与非EP之间存在显著差异(FDR≤5%)。使用逻辑回归模型,计算了每个受试者的EP风险评分,并确定了四个多生物标志物逻辑模型,这些模型的表现相似,auc高于单一预测因子的模型。结论:总体而言,四种多变量逻辑模型比单一生物标志物的逻辑模型具有更好的EP预测效果。模型4 (NOTUM、PAEP、PAPPA、ADAM12)的AUC(0.987)和准确率(96%)最高。然而,由于模型在统计上相似,因此在进一步的验证研究中应考虑四种模型中的所有标记和其他高度相关的标记。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信